Direct and Abscopal Antitumor Responses Elicited by AlPcNE-Mediated Photodynamic Therapy in a Murine Melanoma Model
José Athayde Vasconcelos Morais,Pedro H A Barros,Marcelo de Macedo Brigido,Clara Luna Marina,Anamelia Bocca,André de Lima E Silva Mariano,Paulo E N de Souza,Karen L R Paiva,Marina Mesquita Simões,Sonia Nair Bao,Luana C Camargo,João P Figueiró Longo,Amanda Alencar Cabral Morais,Ricardo B de Azevedo,Marcio J P Fonseca,Luis A Muehlmann
DOI: https://doi.org/10.3390/pharmaceutics16091177
IF: 6.525
2024-09-06
Pharmaceutics
Abstract:Melanoma, the most aggressive form of skin cancer, presents a major clinical challenge due to its tendency to metastasize and recalcitrance to traditional therapies. Despite advances in surgery, chemotherapy, and radiotherapy, the outlook for advanced melanoma remains bleak, reinforcing the urgent need for more effective treatments. Photodynamic therapy (PDT) has emerged as a promising alternative, leading to targeted tumor destruction with minimal harm to surrounding tissues. In this study, the direct and abscopal antitumor effects of PDT in a bilateral murine melanoma model were evaluated. Although only one of the two tumors was treated, effects were observed in both. Our findings revealed significant changes in systemic inflammation and alterations in CD4+ and CD8+ T cell populations in treated groups, as evidenced by blood analyses and flow cytometry. High-throughput RNA sequencing (RNA-Seq) further unveiled shifts in gene expression profiles in both treated and untreated tumors. This research sheds light on the novel antitumor and abscopal effects of nanoemulsion of aluminum chloride phthalocyanine (AlPcNE)-mediated PDT in melanoma, highlighting the potential of different PDT protocols to modulate immune responses and to achieve more effective and targeted cancer treatments.